DIAGNOSTIC PECULARITIES OF METASTASES IN ASCITIC AND PLEURAL FLUID WITH THE USE OF IMMUNOCYTOCHEMICAL METHOD IN PATIENTS WITH SEROUS OVARY CANCER
- Authors: Grigoruk O.G1,2,3, Bogatyrev V.N4, Bazulina L.M2,3, Maksimenko T.A1,2,3, Lazarev A.F1,2,3
-
Affiliations:
- Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
- Altai Oncological Hospital, 656049, Barnaul, Russian Federation
- 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
- N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
- Issue: Vol 18, No 1 (2013)
- Pages: 4-9
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/39934
- DOI: https://doi.org/10.17816/onco39934
- ID: 39934
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O. G Grigoruk
Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences; Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
Email: cytolakod@rambler.ru
канд. биол. наук, зав. отд-нием клинической лабораторной диагностики 656049, Barnaul, Russian Federation
V. N Bogatyrev
N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences115478, Moscow, Russian Federation
L. M Bazulina
Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
T. A Maksimenko
Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences; Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
A. F Lazarev
Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences; Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
References
- Карселадзе А. И. Клинико-морфологическая диагностика опухолей яичника. Архив патологии 2005; прил.: 63.
- Alberti N., Serrano-Egea A., Garcia-García E. et al. Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry. Acta Cytol. 2007; 51 (2): 203—206.
- Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008; 9: 1191—1197.
- Davidson B. The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma. Cytopathology. 2011; 22: 5—21.
- Capitanio A., Natula A., Falson M. Diagnostic pitfall of atipical glandular cells with psammoma bodies in peritoneal waching cytology. J. Cytopathol. 2008, 19 (Suppl. 1: 34th European Congress of Cytology, Rovaniemi, Finland): poster 108; 56.
- Григорук О. Г., Лазарев А. Ф., Богатырёв В. Н. Дифференциальная цитологическая диагностика плевритов. Барнаул: ОАО «ИПП "Алтай"», 2012: 122—4.
- Comin C.E., Saieva C., Messerini L. H-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am. J. Surg. Pathol. 2007; 31 (8): 1139—48.
- McCluggage W. G., Young R. H. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin. Diagn. Pathol. 2005; 22 (1): 3—32.
- Politi E., Kandaraki C., Apostolopoulou C. et al. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn. Cytopathol. 2005; 32: 151—5.
- Su X. Y., Li G. D., Liu W. P. et al. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn. Cytopathol. 2010; 10: 123—7.
- Мельник М. М. Імуногістохімічні технології діагностики метастазів анонімної пухлин. Світ медицини та біології. 2008; 2: 48—56.
- Tot T. Cytokeratyns 20 and 7 as biomarkers usefulness in discriminating primary from metastatic adenocarcinoma. Eur. J. Cancer. 2002; 38 (6): 758—63.
- Heintz A. P., Odicino F., Maisonneuve P. et al. Carcinoma of the ovary FIGO. Int. J. Gynaecol. Obstetr. 2006; 95 (Suppl. 1: 6th Annual report on the results of treatment in gynecological cancer): 161—92.
- Hylander B., Repasky E., Shrikant P. et al. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol. Oncol. 2006; 101: 12—7.
- Zhu W., Michael C. Wt1, Monoclonal CEA, TTF1, and CA125 antibodies in the differencial diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn. Cytopathol. 2007; 35 (6): 370—5.
- Sopel M., Surowiak P., Berdowska I. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma. Folia Morphol. 2010; 69 (4): 204—12.